← Back to Search

Antibiotic

Antibiotic for Liver Cirrhosis (ABX-GV Trial)

Phase 4
Recruiting
Led By Ming-Chih Hou
Research Sponsored by Taipei Veterans General Hospital, Taiwan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Summary

We design a randomized trial to clarify the necessity of antibiotic prophylaxis for the patients chronic liver disease with gastric varices treated by elective GVO.

Eligible Conditions
  • Liver Cirrhosis
  • Gastric Varix
  • Fever
  • Sepsis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Prevetion of sepsis
Secondary study objectives
Mortality
Pevention of Refractory bacterial infection
Rebleeding rate

Side effects data

From 2009 Phase 4 trial • 23 Patients • NCT00535652
20%
Urinary tract infection
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ertapenem

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: AntibioticExperimental Treatment1 Intervention
Participate will be acepted ertapenem(1g) iv before endoscopic cyanoacrylate injection obliteration
Group II: ControlActive Control1 Intervention
Participate will not be acepted ertapenem(1g) iv before endoscopic cyanoacrylate injection obliteration
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ertapenem
FDA approved

Find a Location

Who is running the clinical trial?

Taipei Veterans General Hospital, TaiwanLead Sponsor
405 Previous Clinical Trials
248,689 Total Patients Enrolled
7 Trials studying Liver Cirrhosis
740 Patients Enrolled for Liver Cirrhosis
Ming-Chih HouPrincipal InvestigatorTaipei Veterans General Hospital, Taiwan
~67 spots leftby Dec 2030